Target
Capsid scaffolding protein
Ligand
BDBM50133988
Substrate
n/a
Meas. Tech.
ChEMBL_158964 (CHEMBL769610)
Ki
40±n/a nM
Citation
 Borthwick, ADDavies, DEErtl, PFExall, AMHaley, TMHart, GJJackson, DLParry, NRPatikis, ATrivedi, NWeingarten, GGWoolven, JM Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability. J Med Chem 46:4428-49 (2003) [PubMed]  Article 
Target
Name:
Capsid scaffolding protein
Synonyms:
APNG | Assemblin | Assembly protein | Capsid protein P40 | Human cytomegalovirus protease (HCMV Pr) | Human herpes virus 5 capsid protein P40 | Protease precursor | SCAF_HCMVA | UL80 | pPR
Type:
PROTEIN
Mol. Mass.:
73854.16
Organism:
Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5)
Description:
ChEMBL_158958
Residue:
708
Sequence:
MTMDEQQSQAVAPVYVGGFLARYDQSPDEAELLLPRDVVEHWLHAQGQGQPSLSVALPLNINHDDTAVVGHVAAMQSVRDGLFCLGCVTSPRFLEIVRRASEKSELVSRGPVSPLQPDKVVEFLSGSYAGLSLSSRRCDDVEAATSLSGSETTPFKHVALCSVGRRRGTLAVYGRDPEWVTQRFPDLTAADRDGLRAQWQRCGSTAVDASGDPFRSDSYGLLGNSVDALYIRERLPKLRYDKQLVGVTERESYVKASVSPEAACDIKAASAERSGDSRSQAATPAAGARVPSSSPSPPVEPPSPVQPPALPASPSVLPAESPPSLSPSEPAEAASMSHPLSAAVPAATAPPGATVAGASPAVSSLAWPHDGVYLPKDAFFSLLGASRSAVPVMYPGAVAAPPSASPAPLPLPSYPASYGAPVVGYDQLAARHFADYVDPHYPGWGRRYEPAPSLHPSYPVPPPPSPAYYRRRDSPGGMDEPPSGWERYDGGHRGQSQKQHRHGGSGGHNKRRKETAAASSSSSDEDLSFPGEAEHGRARKRLKSHVNSDGGSGGHAGSNQQQQQRYDELRDAIHELKRDLFAARQSSTLLSAALPSAASSSPTTTTVCTPTGELTSGGGETPTALLSGGAKVAERAQAGVVNASCRLATASGSEAATAGPSTAGSSSCPASVVLAAAAAQAAAASQSPPKDMVDLNRRIFVAALNKLE
  
Inhibitor
Name:
BDBM50133988
Synonyms:
(3S,3aR,6aS)-1-(Cyclopropylcarbonyl)-3-methyl-4-{[(2S)-1-(2-naphthylsulfonyl)pyrrolidin-2-yl]carbonyl}-hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one | (3S,3aR,6aS)-1-Cyclopropanecarbonyl-3-methyl-4-[(S)-1-(naphthalene-2-sulfonyl)-pyrrolidine-2-carbonyl]-hexahydro-pyrrolo[3,2-b]pyrrol-2-one | CHEMBL342043
Type:
Small organic molecule
Emp. Form.:
C26H29N3O5S
Mol. Mass.:
495.591
SMILES:
C[C@H]1[C@@H]2[C@H](CCN2C(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc3ccccc3c2)N(C(=O)C2CC2)C1=O |r|
Structure:
Search PDB for entries with ligand similarity: